Trastuzumab powder for reconstitution for intravenous infusion (IV) Vials

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000540395-2018-08-08T00:00:00Z",
    "date": "2018-08-08T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000540395",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-14",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "name": "Linda Downie",
                "email": "l.downie@nhs.net",
                "telephone": "+44 1698794571",
                "url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        },
        {
            "id": "org-263",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "name": "Linda Downie",
                "email": "l.downie@nhs.net",
                "telephone": "+44 1698794571",
                "url": "http://"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        },
        {
            "id": "org-264",
            "name": "Napp Pharmaceuticals",
            "identifier": {
                "legalName": "Napp Pharmaceuticals"
            },
            "address": {
                "streetAddress": "Milton Road , Science Park",
                "locality": "Cambridge",
                "region": "UK",
                "postalCode": "CB4 0AB"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large",
                "url": "http://"
            }
        },
        {
            "id": "org-265",
            "name": "MSD",
            "identifier": {
                "legalName": "MSD"
            },
            "address": {
                "streetAddress": "HERTFORD ROAD",
                "locality": "HODDESDON",
                "region": "UK",
                "postalCode": "EN11 9BU"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large",
                "url": "http://"
            }
        },
        {
            "id": "org-266",
            "name": "Amgen Ltd",
            "identifier": {
                "legalName": "Amgen Ltd"
            },
            "address": {
                "streetAddress": "240 Cambridge Science Park, Milton Road",
                "locality": "Cambridge",
                "region": "UK",
                "postalCode": "CB4 0WD"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large",
                "url": "http://"
            }
        },
        {
            "id": "org-267",
            "name": "Roche Products Ltd",
            "identifier": {
                "legalName": "Roche Products Ltd"
            },
            "address": {
                "streetAddress": "6 Falcon Way, Shire Park",
                "locality": "Welwyn Garden City",
                "region": "UK",
                "postalCode": "AL7 1TW"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large",
                "url": "http://"
            }
        }
    ],
    "buyer": {
        "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
        "id": "org-263"
    },
    "tender": {
        "id": "NP47418",
        "title": "Trastuzumab powder for reconstitution for intravenous infusion (IV) Vials",
        "description": "Supply of trastuzumab powder for reconstitution for intravenous infusion to Health Boards across NHS Scotland. The procurement will include 150mg and 420mg vials.",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amount": 3278908,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "mainProcurementCategory": "goods",
        "submissionMethod": [
            "electronicSubmission"
        ],
        "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
        "tenderPeriod": {
            "endDate": "2018-05-28T17:00:00Z"
        },
        "awardPeriod": {
            "startDate": "2018-05-28T17:00:00Z"
        },
        "documents": [
            {
                "id": "APR317643",
                "documentType": "contractNotice",
                "title": "Trastuzumab powder for reconstitution for intravenous infusion (IV) Vials",
                "description": "Supply of trastuzumab powder for reconstitution for intravenous infusion to Health Boards across NHS Scotland. The procurement will include 150mg and 440mg vials. Full product details and volumes are included in the ITT",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR317643",
                "format": "text/html"
            },
            {
                "id": "AUG327599",
                "documentType": "awardNotice",
                "title": "Trastuzumab powder for reconstitution for intravenous infusion (IV) Vials",
                "description": "Supply of trastuzumab powder for reconstitution for intravenous infusion to Health Boards across NHS Scotland. The procurement will include 150mg and 420mg vials.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG327599",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "This Framework Agreement is for the supply of trastuzumab powder for reconstitution for intravenous infusion 150mg & 420mg vials to Health Boards across NHS Scotland. Each product line was treated as an individual lot and awarded as an unranked multi supplier framework agreement. It was envisaged that each line would be awarded to a maximum of four (4)Framework Participants.. Access to contract pricing is required by the designated Compounding company for supply to Participating Authorities across NHS Scotland.",
                "status": "complete",
                "value": {
                    "amount": 3278908,
                    "currency": "GBP"
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 540
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "Option to extend by a further two (2) periods of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire."
                },
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "quality",
                            "name": "Logistics",
                            "description": "5"
                        },
                        {
                            "type": "price",
                            "description": "95"
                        }
                    ]
                }
            }
        ],
        "bidOpening": {
            "date": "2018-05-28T17:00:00Z"
        },
        "contractTerms": {
            "hasElectronicPayment": true,
            "hasElectronicOrdering": true,
            "electronicInvoicingPolicy": "allowed"
        },
        "coveredBy": [
            "GPA"
        ],
        "selectionCriteria": {
            "criteria": [
                {
                    "type": "suitability",
                    "description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015"
                },
                {
                    "type": "technical",
                    "description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.",
                    "minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under Technical and Professional ability: Quality Assurance Schemes."
                }
            ]
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "durationInDays": 90
            }
        },
        "techniques": {
            "hasFrameworkAgreement": true,
            "frameworkAgreement": {
                "maximumParticipants": 4
            }
        },
        "classification": {
            "id": "33600000",
            "scheme": "CPV"
        },
        "reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
        "hasRecurrence": false,
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        }
    },
    "language": "EN",
    "description": "The estimated values referred to in Section II.I.5 and II.2.6 covers the eighteen (18) months contract duration and the two (2) twelve (12) month extension periods of the framework agreement. (SC Ref:552673)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000540395"
        },
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000540395"
        }
    ],
    "noticetype": "OJEU - F3 - Contract Award Notice",
    "awards": [
        {
            "id": "NP47418",
            "suppliers": [
                {
                    "id": "org-264",
                    "name": "Napp Pharmaceuticals"
                },
                {
                    "id": "org-265",
                    "name": "MSD"
                },
                {
                    "id": "org-266",
                    "name": "Amgen Ltd"
                },
                {
                    "id": "org-267",
                    "name": "Roche Products Ltd"
                }
            ],
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "NP47418",
            "awardID": "NP47418",
            "status": "active",
            "value": {
                "amount": 2075787,
                "currency": "GBP"
            },
            "dateSigned": "2018-07-10T00:00:00Z"
        }
    ],
    "relatedProcesses": [
        {
            "id": "1",
            "relationship": [
                "planning"
            ],
            "scheme": "EU-OJ",
            "identifier": "2018/S 080-178672"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "269",
                "measure": "bids",
                "value": 4,
                "relatedLot": "1"
            }
        ]
    }
}